Document is current
Any future updates will be listed below
-
Authors
Palaskas, Nicolaos Jay
Garcia, Jacob David
Shirazi, Roksana
Shin, Daniel Sanghoon
Puig-Saus, Cristina
Braas, Daniel
Ribas, Antoni https://orcid.org/0000-0003-3669-8458
Graeber, Thomas Glen https://orcid.org/0000-0001-8574-9181
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 18 September 2019
First Online: 26 November 2019
Conflict of interest
: T.G.G. reports receiving honoraria from Amgen, having consulting and equity relationships with Trethera Corporation. The lab of T.G.G. has completed a research agreement with ImmunoActiva. A.R. reports personal fees from consulting with Amgen, Chugai, Genentech-Roche, Novartis, Merck, Sanofi, and being a member of the scientific advisory board of Arcus, Bioncotech, Compugen, Cytomx, Five Prime, FLX-Bio, Merus, Rgenix, PACT Pharma, and Tango Therapeutics.
